Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

T cell receptor vaccine effective in MS

April 12, 1996

ABT-089 candidate drug for Alzheimer's disease

April 12, 1996

Neruocrine Biosciences, Ciba-Geigy ally for MS research

April 12, 1996

Carbonic anhydrase inhibitor tested for parkinsonism

April 12, 1996

Genentech to develop neurturin for neurodegenerative disorders

April 12, 1996

Genetic markers for manic depression discovered

April 12, 1996

Atypical antipsychotics from Spanish university

April 12, 1996

Generic fluoxetine available in Canada

April 5, 1996

Genentech files for new indication for alteplase

April 5, 1996

Zeneca selects NMDA antagonist for preclinical study

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....